WaratekVRT Sign in

CVE-2026-60683 Oracle Process Manufacturing Regulatory Management

Affected softwareOracle Process Manufacturing Regulatory Management
Affected versions12.2.3-12.2.15
Severity7.7 High CVSS 3.1
Fixed inOracle Critical Patch Update July 2026
WeaknessImproper access control (CWE-284)
Published21 Jul 2026
Updated24 Oct 2026

Description

Vulnerability in the Oracle Process Manufacturing Regulatory Management product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Process Manufacturing Regulatory Management. While the vulnerability is in Oracle Process Manufacturing Regulatory Management, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Process Manufacturing Regulatory Management accessible data. CVSS 3.1 Base Score 7.7 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:N/A:N).

Exploitation status

No public exploit

No exploit has been reported in the sources we check.

  • CISA KEV not listed
  • VulnCheck KEV not listed
  • CISA Vulnrichment exploitation: none
  • Indexed PoC none indexed
  • EPSS 0.35% chance in 30 days

Waratek protection

No exploit published

Within Waratek scope. In the sources we check, nobody has published exploit code for this CVE or reported it being exploited.

This is a proprietary Oracle product. Oracle's security advisory is the source of public detail for this CVE.

  • Protection none
  • Action not pursued
  • Review automated Upstream data
  • Record active
Decided by Nothing to build a rule from yet: no published exploit, no CISA record of exploitation and no source-level change to read
Finding This CVE affects a known product, but nothing published names a fix and nothing published shows an exploit. That is a statement about the evidence, not about the defect — it does not mean the vulnerability is unimportant or unreachable, only that neither of the two things VRT can act on exists.

Affected software and releases

Oracle advisories

AdvisoryTypeQuarterProducts Oracle names in its risk matrix
Oracle Critical Patch Update July 2026 ↗ CPU 2026-Q3 Oracle E-Business Suite / Internal Operations (12.2.3-12.2.15)

Oracle components and versions

FamilyComponentVersions, as Oracle lists themRead as
Oracle E-Business Suite Internal Operations 12.2.3-12.2.15

Products and versions

1 product, 1 version entry
SourceVendorProductSchemeAffected versions
nvd oracle e-business suite generic ≥ 12.2.3 and ≤ 12.2.15

References

URLTags
https://www.oracle.com/security-alerts/cpujul2026.html Vendor Advisory

Timeline

Published2026-07-21By the CVE Program.
NVD record modified2026-10-24NVD's own last-modified date for this record.